14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
Due to pressure from construction workers, officials, and some construction workers having tested po...
Read More >
The line between lawful and unlawful unpaid work is not always clear. Many companies are contacted ...
Read More >
On December 6, 2019, a sharply divided panel of the Second Circuit (covering New York, Connecticut, ...
Read More >
The H-1B process for fiscal year 2021 presents employers and their legal counsel with a variety of n...
Read More >
On January 1, 2020, the new federal overtime rule takes effect. Other than in states with already-h...
Read More >
Coronavirus means building owners and companies need to look at new health standards - Bisnow – M...
Read More >